Revofit™ System Evaluation on Residual Limb Pain in Amputee Patients

July 1, 2022 updated by: University Hospital, Angers

Revofit™ System and Residual Limb Pain in Amputee Patients : Multiple N-of-1 Trial

At the early stage of the amputation, the residual limb presents post-surgical fluctuations related to post-operative phase, which would need a frequent prosthetic adjustment. In most cases, the volume of residual limb is constant from 12 to 18 months after surgery. However, some daily fluctuations could appear due to an underlying vascular disease for example, which could be painful and impact the quality of life with a constant need of prosthetics adjustment. The goal of this study is to assess the effectiveness of a system-adjusted fitting in comparison with a standard fitting.

Study Overview

Detailed Description

With the " multiple N-of-1 trial " study type, pain, quality of life, functional effects and the patient satisfaction with assistive technology will be assessed for four weeks.

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France, 49100
        • DIMONAIS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 18 years old and above
  • Above knee or below knee amputation (irrespective of etiology and time from amputation)
  • Residual limb pain
  • Prosthetic with classic fitting
  • Fluctuations of residual limb requiring prosthetic adaptation (stump cotton sock, wedgning fitting …)
  • Recipients or registered with a social security scheme
  • Informed consent form signed beforehand

Exclusion Criteria:

  • Patient with peripheral neuropathies contraindicating the use of Revofit system
  • Pregnant woman, nursing mother or parturiant
  • Patient in detention by judicial or administrative decision
  • Patient undergoing psychiatric compulsory care
  • Patient in a health or social institution for purposes other than research
  • Legally protected person
  • Patient unable to express their consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adjustable socket
First week of the study is with adjustable socket
All the tests are evaluate during one week with the classical type of fittings
All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)
Experimental: Classical socket
First week of the study is with classical socket
All the tests are evaluate during one week with the classical type of fittings
All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain change assessment
Time Frame: four weeks
Assess the impact of the Revofit™ system adjusted-fitting on residual limb pain compared to a classic fitting with a daily Visual Analog Scale evaluation [VAS : 0 to 10 which constitues the worst outcome].
four weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Everyday comfort
Time Frame: four weeks
Quality of life assessed by daily number of adaptation of the prosthesis
four weeks
Functional effects in twin task
Time Frame: Once a week during four weeks
A walking analysis by GAITrite once a week
Once a week during four weeks
Functional effects in simple task
Time Frame: Once a week during four weeks
A walking analysis by a six-minute walking distance test once a week
Once a week during four weeks
Patient satisfaction with assistive technology
Time Frame: Once a week during four weeks
Assessment of patient satisfaction by using Quebec User Evaluation of Satisfaction with assistive Technology [QUEST] survey
Once a week during four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mickaël Dinomais, MD University hospital Angers
  • Principal Investigator: Yoann RONZI, MD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2021

Primary Completion (Actual)

March 10, 2021

Study Completion (Actual)

March 10, 2021

Study Registration Dates

First Submitted

February 7, 2020

First Submitted That Met QC Criteria

February 17, 2020

First Posted (Actual)

February 19, 2020

Study Record Updates

Last Update Posted (Actual)

July 6, 2022

Last Update Submitted That Met QC Criteria

July 1, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 49RC19_0129

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation

Clinical Trials on Socket without Revofit system

3
Subscribe